Literature DB >> 20226777

Association of GSTT1, GSTM1 and CYP1A1 polymorphisms with susceptibility to systemic lupus erythematosus in the Chinese population.

Jufeng Zhang1, Jingui Deng, Chao Zhang, Yanxin Lu, Li Liu, Qi Wu, Yong Shao, Jie Zhang, Hong Yang, Bo Yu, Jun Wan.   

Abstract

BACKGROUND: GSTT1, GSTM1, CYP1A1 are enzymes responsible for the detoxification of the toxicant which may be involved in the development of systemic lupus erythematosus (SLE). We examined the relationship between the risk of SLE and the polymorphisms of these genes in the Chinese population.
METHODS: Samples from 298 SLE patients and 284 healthy controls were collected. Polymerase chain reaction-restriction fragments length polymorphism (PCR-RFLP) was used to analyze the genotypes of CYP1A1 m2 and m4, while multiplex PCR was used to analyze the genotypes of GSTT1 and GSTM1.
RESULTS: Statistically significant difference was observed in genotypes for GSTM1 (p=0.003, OR 1.66 [95% CI 1.19-2.32]), but not for GSTT1 (p=0.119, OR 0.77 [95% CI 0.56-1.07]), in the SLE patients as compared with the controls. Combinational analysis for double-null deletion of both GSTT1 and GSTM1 showed no significant difference (p=0.863, OR 1.03 [95% CI 0.70-1.52]). Significant difference was observed in the genotype frequencies (p=0.013), but not in the allele frequencies (p=0.444, OR 0.90 [95% CI 0.70-1.17]), of CYP1A1 m2. All candidates have a wild-type genotype for CYP1A1 m4.
CONCLUSIONS: Polymorphisms of GSTM1 are associated with SLE in the Chinese population. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20226777     DOI: 10.1016/j.cca.2010.03.007

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients.

Authors:  Nadine Glesse; Paula Rohr; Odirlei André Monticielo; Tássia Flores Rech; João Carlos Tavares Brenol; Ricardo Machado Xavier; Kátia Kvitko; José Artur Bogo Chies
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

2.  The null polymorphism of the GSTM1/T1 gene is not associated with susceptibility to systemic lupus erythematosus: a meta-analysis.

Authors:  Lechun Lu; Dongyun Lei; Xiang Nong; Meihua Guo; Jiaqing Ma; Li He
Journal:  Mol Diagn Ther       Date:  2015-02       Impact factor: 4.074

3.  Application of Various Statistical Models to Explore Gene-Gene Interactions in Folate, Xenobiotic, Toll-Like Receptor and STAT4 Pathways that Modulate Susceptibility to Systemic Lupus Erythematosus.

Authors:  Yedluri Rupasree; Shaik Mohammad Naushad; Ravi Varshaa; Govindaraj Swathika Mahalakshmi; Konda Kumaraswami; Liza Rajasekhar; Vijay Kumar Kutala
Journal:  Mol Diagn Ther       Date:  2016-02       Impact factor: 4.074

4.  Single-nucleotide polymorphisms and haplotype of CYP2E1 gene associated with systemic lupus erythematosus in Chinese population.

Authors:  Ling-hong Liao; Hao Zhang; Man-Po Lai; Shun-Le Chen; Madeline Wu; Nan Shen
Journal:  Arthritis Res Ther       Date:  2011-01-31       Impact factor: 5.156

Review 5.  Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Chandrasekaran Adithan
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

6.  Association between 3801T>C polymorphism of CYP1A1 and idiopathic male infertility risk: a systematic review and meta-analysis.

Authors:  Haiqing Luo; Hongjiao Li; Na Yao; Liren Hu; Taiping He
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

7.  Combination Effect of GSTM1, GSTT1 and GSTP1 Polymorphisms and Risk of Systemic Lupus Erythematosus.

Authors:  Saeedeh Salimi; Alireza Nakhaee; Mehdi Jafari; Danial Jahantigh; Mahnaz Sandooghi; Zahra Zakeri; Mahnaz Shahrakipour; Anoosh Naghavi; Farzaneh Farajian-Mashhadi
Journal:  Iran J Public Health       Date:  2015-06       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.